Your browser doesn't support javascript.
loading
Roles of Androgen Receptor Signaling in Urothelial Carcinoma.
Sundi, Debasish; Collier, Katharine A; Yang, Yuanquan; Diaz, Dayssy Alexandra; Pohar, Kamal S; Singer, Eric A; Gupta, Sanjay; Carson, William E; Clinton, Steven K; Li, Zihai; Messing, Edward M.
Afiliación
  • Sundi D; Department of Urology, Division of Urologic Oncology, Pelotonia Institute for Immuno-Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Collier KA; Department of Internal Medicine, Division of Medical Oncology, Pelotonia Institute for Immuno-Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Yang Y; Department of Internal Medicine, Division of Medical Oncology, Pelotonia Institute for Immuno-Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Diaz DA; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Pohar KS; Department of Urology, Division of Urologic Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Singer EA; Department of Urology, Division of Urologic Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Gupta S; Department of Urology, Case Western Reserve University School of Medicine, The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
  • Carson WE; Department of Surgery, Division of Surgical Oncology, Pelotonia Institute for Immuno-Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Clinton SK; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Li Z; Department of Internal Medicine, Division of Medical Oncology, Pelotonia Institute for Immuno-Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Messing EM; Departments of Urology, Oncology, and Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Cancers (Basel) ; 16(4)2024 Feb 10.
Article en En | MEDLINE | ID: mdl-38398136
ABSTRACT
Preclinical and clinical data suggest that androgen receptor signaling strongly contributes to bladder cancer development. The roles of the androgen receptor in bladder carcinogenesis have obvious implications for understanding the strong male sex bias in this disease and for potential therapeutic strategies as well. In this review, we summarize what is known about androgen receptor signaling in urothelial carcinoma as well as in tumor-infiltrating immune cells, reviewing preclinical and clinical data. We also highlight clinical trial efforts in this area.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos